Trial Profile

A Phase IIa trial of TS-01 in patients suffering from acute ischemic stroke

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 06 Nov 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TS 01 (Primary)
Indications Ischaemic stroke
Focus Adverse reactions; Proof of concept; Therapeutic Use

Most Recent Events

06 Nov 2019 Planned number of patients changed to 200.
30 Oct 2019 According to a Thrombolytic Science International media release, 10 patients has been enrolled in this study.
06 Sep 2018 According to a Thrombolytic Science media release, this study will be led by Prof. Diederik Dippel, MD, PhD, co-director of the Erasmus MC Stroke Center in Rotterdam, The Netherlands.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com